Clinical Trials Directory

Trials / Completed

CompletedNCT00274391

Efficacy of Amiloride and Hypertonic Saline in Cystic Fibrosis

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
24 (planned)
Sponsor
University of North Carolina · Academic / Other
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to determine whether the combination of inhaled amiloride and a concentrated salt solution is better than the salt solution itself for cystic fibrosis (CF) patients. In CF, airway secretions are thick and dehydrated. Many patients use inhaled salt solutions to help draw water into their secretions so that they are easier to get rid of with chest physiotherapy ("chest PT") and cough. Unfortunately, these salt solutions are reabsorbed very quickly by the airways, so the beneficial effects may not last very long. In the hopes of prolonging their effects, the drug amiloride could be used in combination to slow salt and water reabsorption from airways. Amiloride is a medication that has been given by mouth for high blood pressure for many years. It is possible that the combination of salt solutions and inhaled amiloride may significantly improve the clearance of secretions in CF, which would be expected to improve lung function in CF.

Conditions

Interventions

TypeNameDescription
DRUG7% NaCl
DRUGAmiloride HCl

Timeline

Start date
2001-07-01
Completion
2004-04-01
First posted
2006-01-10
Last updated
2006-01-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00274391. Inclusion in this directory is not an endorsement.

Efficacy of Amiloride and Hypertonic Saline in Cystic Fibrosis (NCT00274391) · Clinical Trials Directory